“Scemblix is the first CML treatment to show significantly better ... with sales last year rising nearly 180% to $413 million from its second-line use and, according to GlobalData, approval ...

Millions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic myeloid leukemia (CML), advancements in treatment selection could ...

Officials are taking steps to ensure minimal traffic disruptions as they prepare for the construction of a new Denver soccer ...

The results of this study support the role for this drug as first-line therapy for CML. Nilotinib is more selective at inhibiting BCR-ABL than any other protein tyrosine kinases, and the ...

CML Unlocks AI’s Full Potential with Enhanced Pattern Recognition, Prediction, and Real-Time Decision-Making for Defense, Autonomous Systems, and Next-Gen Computing BOULDER, Colo., March 20 ...

CML Microsystems plc (LON:CML – Get Free Report) insider Nigel G. Clark bought 9,250 shares of the stock in a transaction on Friday, March 28th. The shares were acquired at an average cost of GBX 215 ...